NDC 54288-142-01 - PAPAVERINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54288-142
- Requested NDC
- 54288-142-01
- Package NDCs from labels
- 54288-142-01, 54288-142-10, 54288-142-25
- Manufacturer
- BPI Labs LLC
- Effective date
- 2025-12-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PAPAVERINE HYDROCHLORIDE - BPI Labs LLC | BPI Labs LLC | 2025-12-26 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54288-142-01 | PAPAVERINE HYDROCHLORIDE | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 9 | |
| 54288-142-10 | PAPAVERINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 9 | |
| 54288-142-25 | PAPAVERINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54288-142-01 | ML - Milliliter | 54288-142 | 6eb04eca-f26b-4dc0-a150-e0cb0b080711 | 1 | 2021-08-05 |
| 54288-142-10 | ML - Milliliter | 54288-142 | 20dd0777-f271-4694-b000-d354ca76d6d3 | 1 | 2021-08-05 |
| 54288-142-25 | ML - Milliliter | 54288-142 | 49a29eb0-d4c2-4435-8489-83c3d51d9ead | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dynamic Eyewash with Eyecup | WATER | Dynamic Safety International | 7d3af0f4-0e1f-9ea5-e053-2991aa0af7a2 | 2018-12-17 | Warnings | 059QF0KO0R |
| Nitrogen | NITROGEN | Air Products and Chemicals, Inc. | e4c5b56e-4c06-4980-8669-6df35e240bf9 | 2018-12-14 | N762921K75 | |
| Bio Rock Water | ROCK WATER | BioActive Nutritional, Inc. | 178bd16d-0d4f-49d8-866b-8ab3a3c6889d | 2018-07-30 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.